Shaanxi Meibang Pharmaceutical Group Co., Ltd. (605033.SS)
CNY 12.67
(-0.63%)
CNY 12.67
(-0.63%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 334.78 Million | 126.41 Million | -108.75 Million | 74.87 Million | 128.44 Million | 16.95 Million |
| Net Income | 57.55 Million | 145.08 Million | 125.74 Million | 78.73 Million | 76.25 Million | 59.33 Million |
| Depreciation & Amortization | 20.87 Million | 15.47 Million | 12.47 Million | 329.12 Thousand | 429.57 Thousand | 335.3 Thousand |
| Deferred income taxes | -4.87 Million | -7.93 Million | 130.88 Thousand | 1.6 Million | 438 Thousand | 414.8 Thousand |
| Stock-based compensation | - | - | - | - | - | 4.83 Million |
| Change in working capital | 246.54 Million | -44.74 Million | -263.45 Million | -18.21 Million | 29.73 Million | -68.84 Million |
| Other non-cash items | -1.27 Million | 10.59 Million | 16.47 Million | 14.02 Million | 22.02 Million | 26.13 Million |
| Investing Cash Flow | -117.17 Million | -34.4 Million | -251.91 Million | -43.49 Million | -22.9 Million | 24.89 Million |
| Investments in PPE | -203.68 Million | -109.28 Million | -106.52 Million | -61.7 Million | -33.78 Million | -34.86 Million |
| Acquisitions | - | 27.81 Thousand | - | 20.35 Thousand | 1.6 Million | - |
| Investment purchases | -1.12 Billion | -933.1 Million | -499 Million | -654 Million | -302 Million | -96.5 Million |
| Sales/Maturities of investments | 1.21 Billion | 1 Billion | 351.9 Million | 669.01 Million | 310.91 Million | 155.8 Million |
| Other Investing Activities | 1.99 Million | 2.74 Million | 1.7 Million | 3.17 Million | 356.69 Thousand | 449.25 Thousand |
| Financing Cash Flow | -58.41 Million | 41.83 Million | 350.58 Million | -59.69 Million | 21.92 Million | 15.2 Million |
| Debt repayment | -1 Million | -67.05 Million | -177 Million | -40 Million | -81 Million | -89 Million |
| Dividends payments | -29.74 Million | -25.68 Million | -3.29 Million | -699.03 Thousand | -2.07 Million | -3.58 Million |
| Common Stock Repurchased | -25.91 Million | -25.56 Million | - | - | - | - |
| Common Stock Issuance | - | 25.56 Million | - | - | - | - |
| Other Financing Activities | -29.59 Million | 135.55 Million | 530.87 Million | -19 Million | 104.99 Million | 107.78 Million |
| Accounts receivables | 98.49 Million | -57.22 Million | -105.48 Million | -49.96 Million | 10.88 Million | 15.54 Million |
| Accounts payables | 67.44 Million | -71.89 Million | 135.8 Million | 49.96 Million | -10.88 Million | - |
| Inventory | 85.47 Million | 92.3 Million | -293.9 Million | -48.06 Million | 47.09 Million | -84.67 Million |
| Other working capital | 62.56 Million | -7.93 Million | 130.88 Thousand | 29.84 Million | -17.35 Million | 15.83 Million |
| Cash at beginning of period | 293.23 Million | 159.38 Million | 169.41 Million | 197.73 Million | 70.26 Million | 13.21 Million |
| Cash at end of period | 452.43 Million | 293.23 Million | 159.38 Million | 169.41 Million | 197.73 Million | 70.26 Million |
| Capital Expenditure | -203.68 Million | -109.28 Million | -106.52 Million | -61.7 Million | -33.78 Million | -34.86 Million |
| Effect of forex changes on cash | 0.15 | 0.34 | 58.64 Thousand | -10.59 Thousand | -256.31 | 249.59 |
| Net cash flow / Change in cash | 159.19 Million | 133.84 Million | -10.02 Million | -28.32 Million | 127.47 Million | 57.05 Million |
| Free Cash Flow | 131.09 Million | 17.12 Million | -215.28 Million | 13.16 Million | 94.66 Million | -17.9 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.15 Million | 2.98 Million | 44.43 Million | 57.55 Million | -12.63 Million | -3.41 Million |
| Depreciation & Amortization | - | 5.52 Million | 5.52 Million | 20.87 Million | 19.61 Million | -9.24 Million |
| Deferred income taxes | - | - | - | -4.87 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -123.16 Million | - | 246.54 Million | 183.97 Million | -39.14 Million |
| Other non-cash items | 249.58 Million | -120.23 Million | -66.08 Million | -1.27 Million | 57.15 Million | 213.35 Million |
| Investing Cash Flow | -39.73 Million | -55.63 Million | -233.64 Million | -117.17 Million | 18.51 Million | -114.16 Million |
| Investments in PPE | -65.95 Million | 788.35 Thousand | -49.31 Million | -203.68 Million | -70.94 Million | -78.09 Million |
| Acquisitions | 0.05 | -0.03 | 6013.48 | - | - | - |
| Investment purchases | -302 Million | -487 Million | -578 Million | -1.12 Billion | -270 Million | -258 Million |
| Sales/Maturities of investments | 327 Million | 431 Million | 393.24 Million | 1.21 Billion | 358.97 Million | 221.67 Million |
| Other Investing Activities | 1.21 Million | 490.23 Thousand | 421.41 Thousand | 1.99 Million | 481.18 Thousand | 247.31 Thousand |
| Financing Cash Flow | -640.51 Thousand | 66.11 Million | -12.55 Million | -58.41 Million | -21.35 Million | -973.28 Thousand |
| Debt repayment | - | -72 Million | - | -1 Million | - | -1.07 Million |
| Dividends payments | - | -20.2 Million | -9479.17 | -29.74 Million | -284.05 Thousand | -9583.34 |
| Common Stock Repurchased | - | - | - | -25.91 Million | -25.91 Million | 25.56 Million |
| Common Stock Issuance | - | - | - | - | - | -25.56 Million |
| Other Financing Activities | -640.51 Thousand | -5.88 Million | -12.54 Million | -29.59 Million | -21.64 Million | 106.3 Thousand |
| Accounts receivables | - | -291.41 Million | - | 98.49 Million | 98.49 Million | 121.75 Million |
| Accounts payables | - | - | - | 67.44 Million | - | - |
| Inventory | - | 168.24 Million | - | 85.47 Million | 85.47 Million | -160.9 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 99.25 Million | 225.86 Million | 452.43 Million | 293.23 Million | 207.16 Million | 160.52 Million |
| Cash at end of period | 304.94 Million | 99.25 Million | 184.58 Million | 452.43 Million | 452.43 Million | 207.16 Million |
| Capital Expenditure | -65.95 Million | 788.35 Thousand | -49.31 Million | -203.68 Million | -70.94 Million | -78.09 Million |
| Effect of forex changes on cash | - | 0.01 | - | 0.15 | - | 233.01 Thousand |
| Net cash flow / Change in cash | 205.69 Million | -126.6 Million | -267.84 Million | 159.19 Million | 245.26 Million | 46.64 Million |
| Free Cash Flow | 179.47 Million | -121.98 Million | -70.96 Million | 131.09 Million | 177.15 Million | 83.45 Million |
AUSTENG
RBT
8984
KARMAENG
ELAND
CCAJ